RhumbLine Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.51K | Hold |
|
|||||
|
2025
Q2 | $1.51K | Hold |
|
|||||
|
2025
Q1 | $1.51K | Hold |
|
|||||
|
2024
Q4 | $1.51K | Hold |
|
|||||
|
2024
Q3 | $1.51K | Hold |
|
|||||
|
2024
Q2 | $1.51K | Hold |
|
|||||
|
2024
Q1 | $1.51K | Hold |
|
|||||
|
2023
Q4 | $1.51K | Hold |
|
|||||
|
2023
Q3 | $1.51K | Hold |
|
|||||
|
2023
Q2 | $1.51K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $621K | Sell |
|
|||||
|
2020
Q2 | $656K | Buy |
|
|||||
|
2020
Q1 | $625K | Buy |
|
|||||
|
2019
Q4 | $686K | Sell |
|
|||||
|
2019
Q3 | $457K | Buy |
|
|||||
|
2019
Q2 | $618K | Sell |
|
|||||
|
2019
Q1 | $805K | Buy |
|
|||||
|
2018
Q4 | $627K | Buy |
|
|||||
|
2018
Q3 | $411K | Sell |
|
|||||
|
2018
Q2 | $369K | Sell |
|
|||||
|
2018
Q1 | $486K | Sell |
|
|||||
|
2017
Q4 | $469K | Sell |
|
|||||
|
2017
Q3 | $706K | Buy |
|
|||||
|
2017
Q2 | $508K | Sell |
|
|||||
|
2017
Q1 | $482K | Buy |
|
|||||
|
2016
Q4 | $436K | Sell |
|
|||||
|
2016
Q3 | $715K | Buy |
|
|||||
|
2016
Q2 | $669K | Sell |
|
|||||
|
2016
Q1 | $889K | Buy |
|
|||||
|
2015
Q4 | $855K | Buy |
|
|||||
|
2015
Q3 | $1.15M | Buy |
|
|||||
|
2015
Q2 | $1.42M | Buy |
|
|||||
|
2015
Q1 | $1.27M | Buy |
|
|||||
|
2014
Q4 | $1.14M | Sell |
|
|||||
|
2014
Q3 | $1.11M | Sell |
|
|||||
|
2014
Q2 | $2.29M | Buy |
|
|||||
|
2014
Q1 | $1.92M | Buy |
|
|||||
|
2013
Q4 | $1.24M | Sell |
|
|||||
|
2013
Q3 | $1.17M | Sell |
|
|||||
|
2013
Q2 | $1.14M | Buy |
|